CBD /

 

Loading...
Country's Decision or any other Communication (DEC)
  |  
BCH-DEC-JP-102146-2   |   PDF   |   Print   |  
| 
|  Close
last updated: 11 Aug 2011
Amendment
No
General Information
Japan
Approval of Type 1 Use Regulations
EN
20 Jun 2011
No
Subject of the decision, notification, communication or declaration
  • Decision on LMOs for intentional introduction into the environment (according to Article 10 or domestic regulatory framework)
LMOs for intentional introduction into the environment
No
No
Yes
No
Yes
Result of the decision
Approval of the import and/or use of the LMO(s) without conditions
LMO identification & risk assessment
  • BCH-LMO-SCBD-102156-4 Living Modified Organism Rice vaccine against cedar pollen allergy
    National Institute of Agrobiological Sciences(NIAS) | Production of medical or pharmaceutical compounds (human or animal) (Antibodies and antigens, Vaccines), Resistance to antibiotics (Hygromycin)
  • BCH-RA-JP-102145-3 Risk Assessment generated by a regulatory process Rice containing ceder pollen (modified Cry j transgenic rice, Oryza Sativa L.
    Rice vaccine against cedar pollen allergy | Rice, ORYSA, Resistance to antibiotics, Production of medical or pharmaceutical compounds (human or animal)
Document on the decision, communication, notification or declaration

Quick links

About the BCH About the Cartagena Protocol Supplementary Protocol

Sign in Search records Submit records
Registries: LMO-Organism-Gene Country Profiles
National Report Analyzer

Forums BCH Announcements

Need help?

Knowledge Base FAQs UNEP eLearning Training Site

Contact us at: bch@cbd.int
BCH Biosafety Clearing-House
Subscribe to e-mail notifications
Subscribe to our newsletter